These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 26646488)

  • 1. Drugs that made headlines in 2015.
    Chakradhar S
    Nat Med; 2015 Dec; 21(12):1382-3. PubMed ID: 26646488
    [No Abstract]   [Full Text] [Related]  

  • 2. Considerations in the early development of biosimilar products.
    Li EC; Abbas R; Jacobs IA; Yin D
    Drug Discov Today; 2015 May; 20 Suppl 2():1-9. PubMed ID: 25572407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Biosimilars battle rages on, Amgen fights both sides.
    Senior M
    Nat Biotechnol; 2013 Apr; 31(4):269-70. PubMed ID: 23563402
    [No Abstract]   [Full Text] [Related]  

  • 4. Biosimilar draft guidance issue by US FDA.
    Payne T
    Bioanalysis; 2012 Apr; 4(7):759. PubMed ID: 22512794
    [No Abstract]   [Full Text] [Related]  

  • 5. First US biosimilar edges towards market.
    Senior M
    Nat Biotechnol; 2015 Mar; 33(3):222-3. PubMed ID: 25748898
    [No Abstract]   [Full Text] [Related]  

  • 6. FDA sets hierarchy for biosimilars evidence.
    Ratner M
    Nat Biotechnol; 2014 Jul; 32(7):609. PubMed ID: 25004221
    [No Abstract]   [Full Text] [Related]  

  • 7. First biosimilar drug approved for sale in the United States.
    Hede K
    J Natl Cancer Inst; 2015 Jul; 107(7):. PubMed ID: 26142444
    [No Abstract]   [Full Text] [Related]  

  • 8. Show drugs work before selling them.
    Sipp D; McCabe C; Rasko JE
    Nature; 2017 Mar; 543(7644):174-175. PubMed ID: 28277530
    [No Abstract]   [Full Text] [Related]  

  • 9. [Biosimilar medicines. Scientific and legal disputes].
    Dorantes Calderón B; Montes Escalante IM
    Farm Hosp; 2010 Mar; 34 Suppl 1():29-44. PubMed ID: 20920856
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Perspectives on the Current State of the Biosimilar Regulatory Pathway in the United States.
    Dougherty MK; Zineh I; Christl L
    Clin Pharmacol Ther; 2018 Jan; 103(1):36-38. PubMed ID: 29152721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fresh from the biotech pipeline--2013.
    Kling J
    Nat Biotechnol; 2014 Feb; 32(2):121-4. PubMed ID: 24509747
    [No Abstract]   [Full Text] [Related]  

  • 12. Drugs that made headlines in 2016.
    Keener AB
    Nat Med; 2016 Dec; 22(12):1377-1379. PubMed ID: 27923025
    [No Abstract]   [Full Text] [Related]  

  • 13. Advancing Biosimilar Development Using Pharmacodynamic Biomarkers in Clinical Pharmacology Studies.
    Li J; Florian J; Campbell E; Schrieber SJ; Bai JPF; Weaver JL; Hyland PL; Thway TM; Matta MK; Lankapalli RH; Narayanasamy S; Dancy J; Zusterzeel R; Tyson JY; Prentice KW; Jackson KC; Patel V; Rouse RL; Wang YC; Strauss DG
    Clin Pharmacol Ther; 2020 Jan; 107(1):40-42. PubMed ID: 31667825
    [No Abstract]   [Full Text] [Related]  

  • 14. FDA issues guidelines for biosimilar drugs.
    Cancer Discov; 2012 Mar; 2(3):196. PubMed ID: 22585973
    [No Abstract]   [Full Text] [Related]  

  • 15. Patent watch: Have the biosimilar floodgates been opened in the United States?
    Brinckerhoff CC; Schorr K
    Nat Rev Drug Discov; 2015 May; 14(5):303-4. PubMed ID: 25924576
    [No Abstract]   [Full Text] [Related]  

  • 16. Biosimilar safety factors in clinical practice.
    Reinisch W; Smolen J
    Semin Arthritis Rheum; 2015 Jun; 44(6 Suppl):S9-15. PubMed ID: 26058551
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Assessing biosimilarity and interchangeability of biosimilar products.
    Chow SC
    Stat Med; 2013 Feb; 32(3):361-3. PubMed ID: 23307569
    [No Abstract]   [Full Text] [Related]  

  • 18. Zarxio--a filgrastim biosimilar.
    Med Lett Drugs Ther; 2016 Mar; 58(1490):34-5. PubMed ID: 26963154
    [No Abstract]   [Full Text] [Related]  

  • 19. The right to a trial: Should dying patients have access to experimental drugs?
    Groopman J
    New Yorker; 2006 Dec; ():40-7. PubMed ID: 17176539
    [No Abstract]   [Full Text] [Related]  

  • 20. Stakeholders discuss biosimilar naming, substitution.
    Traynor K
    Am J Health Syst Pharm; 2014 Mar; 71(6):446-7. PubMed ID: 24589534
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.